These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31494293)

  • 1. Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in CXCR4
    Sala R; Sánchez-García L; Serna N; Céspedes MV; Casanova I; Roldán M; Sánchez-Chardi A; Unzueta U; Vázquez E; Mangues R; Villaverde A
    Acta Biomater; 2019 Nov; 99():426-432. PubMed ID: 31494293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4
    Céspedes MV; Unzueta U; Álamo P; Gallardo A; Sala R; Casanova I; Pavón MA; Mangues MA; Trías M; López-Pousa A; Villaverde A; Vázquez E; Mangues R
    Nanomedicine; 2016 Oct; 12(7):1987-1996. PubMed ID: 27085904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles.
    Unzueta U; Céspedes MV; Ferrer-Miralles N; Casanova I; Cedano J; Corchero JL; Domingo-Espín J; Villaverde A; Mangues R; Vázquez E
    Int J Nanomedicine; 2012; 7():4533-44. PubMed ID: 22923991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicines.
    Álamo P; Cedano J; Conchillo-Sole O; Cano-Garrido O; Alba-Castellon L; Serna N; Aviñó A; Carrasco-Diaz LM; Sánchez-Chardi A; Martinez-Torró C; Gallardo A; Cano M; Eritja R; Villaverde A; Mangues R; Vazquez E; Unzueta U
    Acta Biomater; 2021 Aug; 130():211-222. PubMed ID: 34116228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruiting potent membrane penetrability in tumor cell-targeted protein-only nanoparticles.
    Serna N; Sánchez JM; Unzueta U; Sánchez-García L; Sánchez-Chardi A; Mangues R; Vázquez E; Villaverde A
    Nanotechnology; 2019 Mar; 30(11):115101. PubMed ID: 30561375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fusogenic peptide HA2 impairs selectivity of CXCR4-targeted protein nanoparticles.
    Sánchez-García L; Serna N; Mattanovich M; Cazzanelli P; Sánchez-Chardi A; Conchillo-Solé O; Cortés F; Daura X; Unzueta U; Mangues R; Villaverde A; Vázquez E
    Chem Commun (Camb); 2017 Apr; 53(33):4565-4568. PubMed ID: 28322369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective CXCR4
    Díaz R; Pallarès V; Cano-Garrido O; Serna N; Sánchez-García L; Falgàs A; Pesarrodona M; Unzueta U; Sánchez-Chardi A; Sánchez JM; Casanova I; Vázquez E; Mangues R; Villaverde A
    Small; 2018 Jun; 14(26):e1800665. PubMed ID: 29845742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CXCR4-targeted nanocarrier achieves highly selective tumor uptake in diffuse large B-cell lymphoma mouse models.
    Falgàs A; Pallarès V; Unzueta U; Céspedes MV; Arroyo-Solera I; Moreno MJ; Sierra J; Gallardo A; Mangues MA; Vázquez E; Villaverde A; Mangues R; Casanova I
    Haematologica; 2020 Mar; 105(3):741-753. PubMed ID: 31248974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective delivery of T22-PE24-H6 to CXCR4
    Falgàs A; Pallarès V; Serna N; Sánchez-García L; Sierra J; Gallardo A; Alba-Castellón L; Álamo P; Unzueta U; Villaverde A; Vázquez E; Mangues R; Casanova I
    Theranostics; 2020; 10(12):5169-5180. PubMed ID: 32373205
    [No Abstract]   [Full Text] [Related]  

  • 10. Switching cell penetrating and CXCR4-binding activities of nanoscale-organized arginine-rich peptides.
    Favaro MTP; Serna N; Sánchez-García L; Cubarsi R; Roldán M; Sánchez-Chardi A; Unzueta U; Mangues R; Ferrer-Miralles N; Azzoni AR; Vázquez E; Villaverde A
    Nanomedicine; 2018 Aug; 14(6):1777-1786. PubMed ID: 29777875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective depletion of metastatic stem cells as therapy for human colorectal cancer.
    Céspedes MV; Unzueta U; Aviñó A; Gallardo A; Álamo P; Sala R; Sánchez-Chardi A; Casanova I; Mangues MA; Lopez-Pousa A; Eritja R; Villaverde A; Vázquez E; Mangues R
    EMBO Mol Med; 2018 Oct; 10(10):. PubMed ID: 30190334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted Nanoparticles.
    Álamo P; Pallarès V; Céspedes MV; Falgàs A; Sanchez JM; Serna N; Sánchez-García L; Voltà-Duràn E; Morris GA; Sánchez-Chardi A; Casanova I; Mangues R; Vazquez E; Villaverde A; Unzueta U
    Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33105866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4.
    Pallarès V; Núñez Y; Sánchez-García L; Falgàs A; Serna N; Unzueta U; Gallardo A; Alba-Castellón L; Álamo P; Sierra J; Villaverde A; Vázquez E; Casanova I; Mangues R
    J Control Release; 2021 Jul; 335():117-129. PubMed ID: 34004204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma.
    Rioja-Blanco E; Arroyo-Solera I; Álamo P; Casanova I; Gallardo A; Unzueta U; Serna N; Sánchez-García L; Quer M; Villaverde A; Vázquez E; León X; Alba-Castellón L; Mangues R
    J Exp Clin Cancer Res; 2022 Feb; 41(1):49. PubMed ID: 35120582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4
    Falgàs A; Pallarès V; Unzueta U; Núñez Y; Sierra J; Gallardo A; Alba-Castellón L; Mangues MA; Álamo P; Villaverde A; Vázquez E; Mangues R; Casanova I
    Int J Nanomedicine; 2021; 16():1869-1888. PubMed ID: 33716502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A refined cocktailing of pro-apoptotic nanoparticles boosts anti-tumor activity.
    Sánchez-García L; Sala R; Serna N; Álamo P; Parladé E; Alba-Castellón L; Voltà-Durán E; Sánchez-Chardi A; Unzueta U; Vázquez E; Mangues R; Villaverde A
    Acta Biomater; 2020 Sep; 113():584-596. PubMed ID: 32603867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases.
    Sala R; Rioja-Blanco E; Serna N; Sánchez-García L; Álamo P; Alba-Castellón L; Casanova I; López-Pousa A; Unzueta U; Céspedes MV; Vázquez E; Villaverde A; Mangues R
    Drug Deliv; 2022 Dec; 29(1):1384-1397. PubMed ID: 35532120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticles.
    Tarasov SG; Gaponenko V; Howard OM; Chen Y; Oppenheim JJ; Dyba MA; Subramaniam S; Lee Y; Michejda C; Tarasova NI
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9798-803. PubMed ID: 21628584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4
    Falgàs A; Garcia-León A; Núñez Y; Serna N; Sánchez-Garcia L; Unzueta U; Voltà-Durán E; Aragó M; Álamo P; Alba-Castellón L; Sierra J; Gallardo A; Villaverde A; Vázquez E; Mangues R; Casanova I
    Biomed Pharmacother; 2022 Jun; 150():112940. PubMed ID: 35421785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering Secretory Amyloids for Remote and Highly Selective Destruction of Metastatic Foci.
    Céspedes MV; Cano-Garrido O; Álamo P; Sala R; Gallardo A; Serna N; Falgàs A; Voltà-Durán E; Casanova I; Sánchez-Chardi A; López-Laguna H; Sánchez-García L; Sánchez JM; Unzueta U; Vázquez E; Mangues R; Villaverde A
    Adv Mater; 2020 Feb; 32(7):e1907348. PubMed ID: 31879981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.